TY  - GEN
AU  - Alyea,Edwin P
AU  - Li,Shuli
AU  - Kim,Haesook T
AU  - Cutler,Corey
AU  - Ho,Vincent
AU  - Soiffer,Robert J
AU  - Antin,Joseph H
TI  - Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation
SN  - 1523-6536
PY  - 2008///1031
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Busulfan
KW  - therapeutic use
KW  - Female
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - drug therapy
KW  - Hematologic Neoplasms
KW  - complications
KW  - Histocompatibility Testing
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Peripheral Blood Stem Cell Transplantation
KW  - adverse effects
KW  - Premedication
KW  - Sirolimus
KW  - Tacrolimus
KW  - Tissue Donors
KW  - Transplantation Conditioning
KW  - methods
KW  - Transplantation, Homologous
KW  - Vidarabine
KW  - analogs & derivatives
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.bbmt.2008.05.024
ER  -